First in Human Study of UCT-01-097 in Participants With Advanced Solid Tumors
Clinical trial NCT04761601 · TERMINATED
Trial details
- NCT number
- NCT04761601
- Sponsor
- 1200 Pharma, LLC
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-03
- Primary completion
- 2024-02-19
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.